Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

Clinical trial NCT00366834 · COMPLETED

Trial details

NCT number: NCT00366834
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vomiting Nausea Nausea and Vomiting, Chemotherapy-Induced

Start date: 2006-07-01
Primary completion: 2007-10-01
Enrollment: 1840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.